Healthy volunteers test new drug formulations in Early-Stage study
NCT ID NCT06911567
First seen Jan 19, 2026 · Last updated Apr 28, 2026 · Updated 17 times
Summary
This study tested new versions of a drug called TEV-56286 to see how well they are absorbed compared to the original capsule form. It involved 47 healthy adults who took single doses of different formulations. The main goal was to measure drug levels in the blood and check for any side effects. This is an early-stage study, so it does not aim to treat or cure any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Teva Investigational Site 12141
Miramar, Florida, 33025, United States
Conditions
Explore the condition pages connected to this study.